Affiliate disclosure
Book titles on this page link to Amazon. As an Amazon Associate, DataField.Dev earns from qualifying purchases — at no additional cost to you.
Chapter 18 — Further Reading
⚠️ Read one from each side — deliberately
This is the first chapter where I'd ask you to do that rather than suggest it. §18.15 argues both positions are held by serious people who can name disconfirming evidence. You cannot check that claim by reading only the side you find congenial.
Robert Lustig, Fat Chance — the most influential popular statement of the strong position. Lustig is a paediatric endocrinologist, and his 2009 lecture "Sugar: The Bitter Truth" is on YouTube and has been viewed many millions of times. ⚠️ Read it as the best version of the case, and note where it slides between §18.1's four claims. The hepatic mechanism is real; watch how far it's asked to travel.
Gary Taubes, The Case Against Sugar — a thorough, well-researched historical account of the sugar industry and the science. ⚠️ His method is worth studying independently of his conclusions: he is a skilled and selective marshaller of evidence, and reading him alongside Chapter 9's treatment of the Keys cherry-picking charge is a genuinely useful exercise in noticing what a good argument leaves out.
For the other side: search for Stephan Guyenet's critiques of the fructose hypothesis, and his book The Hungry Brain, which locates the problem in food reward and energy intake rather than in a specific molecule. ⚠️ He engages with Lustig's actual arguments rather than a caricature, which is rarer than it should be.
And then read the fourth thing: the WHO's 2015 guideline on sugars intake (who.int), free.
⚠️ A guideline document written by people who had to reach a defensible position rather than win an
argument. The difference in tone from the three books above is itself informative.
On fructose metabolism
Start with the intestinal clearance work — search "fructose small intestine clearance liver spillover" and look for the primary studies from the late 2010s. ⚠️ This is the finding that reframed the debate and it is still poorly represented in popular discussion on both sides.
On de novo lipogenesis: search "de novo lipogenesis fructose human quantitative". ⚠️ Pay attention to whether each study is isocaloric or overfeeding — §18.4 argues this is the single most important thing to check, and it is usually in the methods rather than the abstract.
On NAFLD: search for reviews on "non-alcoholic fatty liver disease dietary fructose" and note how carefully the better ones separate the association from the causal claim. (Nomenclature is shifting — you may also see MASLD, metabolic dysfunction-associated steatotic liver disease.)
On sugar-sweetened beverages
Search "liquid calories compensation satiety" for the primary experimental work — §18.7's core finding, and it's more interesting in the original than in summary.
On the trials: search "sugar-sweetened beverage randomized trial adolescent weight". ⚠️ Note how few there are and how short they run. This is a well-supported conclusion built on a genuinely small trial base plus strong convergence — which is what ✅ means in this book, and not more.
On fruit versus juice: search "whole fruit fruit juice type 2 diabetes cohort". The large US cohorts are the usual source. Read the discussion sections for how the authors handle confounding — they are more candid than the press coverage.
On soda taxes
The UK Soft Drinks Industry Levy — search for HM Treasury documentation on its structure, then for published evaluations of reformulation. ⚠️ Understand the tiering and the two-year notice before reading any evaluation, or you'll misattribute the mechanism (Case Study 2).
Mexico's 2014 tax — search "Mexico sugar-sweetened beverage tax evaluation purchases". ⚠️ Look for whether the analysis handles substitution.
And the sceptical literature, which you should read: search for critiques addressing cross-border shopping, substitution to untaxed beverages, and the gap between purchasing and health outcomes. ⚠️ Case Study 2's honest verdict came out of this literature, not despite it.
On the industry history
Kearns CE, Glantz SA, Schmidt LA (2016), JAMA Internal Medicine — the Sugar Research Foundation paper. ⚠️ Read the primary paper, not a summary of it. The recovered correspondence is quoted, and seeing the actual documents is different from being told they exist. This is what §18.12's test looks like when it passes.
The UCSF Industry Documents Library (industrydocuments.ucsf.edu) — the archive itself, free and
searchable. ⚠️ Originally built for the tobacco litigation documents and now much broader.
An hour here will do more for your instincts about industry influence than any book, in both
directions: you will find real misconduct, and you will find that most of the archive is boring.
On Yudkin: his Pure, White and Deadly (1972) is worth reading as a historical document. ⚠️ Then search for critical assessments of the "Yudkin was suppressed" narrative — it is considerably more complicated than the popular telling, and §18.12's third qualification comes from there.
On sweeteners
The 2023 IARC and JECFA aspartame evaluations — ⚠️ read the WHO's own explanatory material on the difference between hazard identification and risk assessment. It is short and it will permanently improve how you read health headlines.
The WHO 2023 guideline on non-sugar sweeteners — free at who.int. ⚠️ Read the certainty ratings
and the "conditional" designation, not the headline. The guideline is much more careful than its
coverage was, and the gap between the two is a Chapter 1 §1.4 pipeline case study you can verify
yourself.
Practical tools
Your national added-sugar labelling rules. ⚠️ US: "Added Sugars" is a separate line — use it. UK/EU: "of which sugars" is total, so you must read the ingredient list. Learn the aliases: sucrose, glucose syrup, invert sugar, maltodextrin, dextrose, fruit juice concentrate, molasses, rice syrup, agave nectar.
Action on Sugar (actiononsugar.org) — UK campaign group with product surveys. ⚠️ Read them
knowing they are a campaign group with a position — Chapter 1 §1.5's question applies to advocates as
well as to industry.
A note on what to be careful with
⚠️ This chapter's specific risk is that a reader takes "it's mostly calories" as permission and "sugar is toxic" as refuted, and stops there.
Three things that should survive the deflation:
1. §18.7 is ✅. The SSB evidence is among the strongest in this book. ⚠️ Nothing in the fructose debate touches it, because it doesn't depend on the fructose debate at all.
2. NAFLD is real and rising. Rejecting the alcohol analogy (🟠) is not the same as rejecting the concern that produced it.
3. §18.12 is documented. ⚠️ Do not let Chapter 17's tells train you to dismiss a real archive.
And the opposite risk, for the reader who came in on the other side:
⚠️ If you finish this chapter still believing sugar is uniquely toxic, ask yourself what §18.15's last row says you'd accept as evidence against it — and whether the isocaloric substitution trials, which already exist, count. If nothing counts, you're not holding a scientific position, and Chapter 17 §17.1 has a name for that shape.
Both failure modes are the same failure, which is deciding first and grading the evidence afterwards. Part IV will keep offering you the chance to do it.